Understanding this pathway, in addition to the fact that glutamine metabolism is upregulated in GBM cells, has prompted discoveries of various metabolic modulators, including GLS and GDH inhibitors, targeting the energetic advantage this pathway provides. Here, GLUD1 is linked to glioblastoma.